Shutting Down Inflammation Reverses Damage from Spinal Cord Injury

Author: Georgetown University Medical Center
Published: 2009/03/31
Topic: Spinal Cord Injury (SCI) - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: Researchers have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies.

Introduction

Researchers at Georgetown University Medical Center (GUMC) have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies.

Main Item

By Shutting Down Inflammation, Agent Reverses Damage from Spinal Cord Injury in Pre-clinical Studies.

Researchers at Georgetown University Medical Center (GUMC) have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in pre-clinical studies.

Their research, published online in Annals of Neurology and led by Kimberly Byrnes, PhD, shows that inflammation following injury causes the neurotoxicity that leads to lasting nerve cell damage, and that an experimental agent is able to block this inflammatory reaction.

"The findings we have made in this study may potentially be applicable to other neurological disorders, including stroke, head injury, Alzheimer's disease and Parkinson's disease," says senior investigator Alan I. Faden, MD, a professor of neuroscience and director of the Laboratory for the Study of Central Nervous System Injury at GUMC.

Faden says that the experimental agent they tested (CHPG), an activator of a type of glutamate receptor, is not ideal for human use because it cannot easily penetrate the blood-brain barrier. But he adds, "now that we know the biological target, a new drug could be designed that is better suited for clinical treatment of these neurodegenerative disorders."

CHPG shuts down activation of key immune cells in the brain known as microglia, which sense pathogens or damage in the spinal cord and brain. They helpfully foster the destruction of microbial invaders and clean up biological detritus that occurs after an injury, but researchers say they have a dark side as well - they can worsen the damage by releasing toxic inflammatory factors.

"Under certain conditions, like spinal cord injury and brain trauma, microglia become activated," Faden says. "They release toxic chemicals that can kill healthy adjacent tissue, and this process can continue for months.

"We have found that six months after an injury, the expression of certain inflammatory factors in the spinal cord is 4-5 times normal levels," he says, adding that it has been shown that after human trauma, brain tissue can continue to be lost even more than a year after the injury. "Microglial related toxicity may contribute to this progressive loss," says Faden.

The study is a continuation of a long line of research by this investigative group that aims to stop that persistent damage. The team had previously found that microglial cells express a certain receptor, the group I metabotropic glutamate receptor 5 (mGluR5), on their surface. Further work showed that if these receptors were specifically activated on microglia, these immune cells would not produce the neurotoxins that led to cell death near the site of injury. CHPG serves to selectively activate the receptor, reducing microglial toxicity.

The study was funded by grants from the National Institute of Neurological Diseases and Stroke. Faden and Byrnes are co-inventors on a patent application that has been filed by Georgetown University related to the technology that is described in this paper. The other co-authors are Bogdan Stoica, MD, Angela Riccio, BS, Ahdeah Pajoohesh-Ganjai, PhD, and David J. Loane, PhD, all from the Department of Neuroscience at GUMC.

Reference: Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through our partnership with MedStar Health). Our mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis - or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university's sponsored research funding.

Explore Similar Topics

- New research demonstrates the autonomous learning and memory capabilities of spinal cord neurons, highlighting their independence from cerebral control.

- Patients often not satisfied with treatment for myelopathy when they have severe residual paresthesia, even when function and quality of life are improved after surgery.

Citing Information and Page References

Disabled World (DW) is a comprehensive online resource providing information and news related to disabilities, assistive technologies, and accessibility. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Georgetown University Medical Center. (2009, March 31). Shutting Down Inflammation Reverses Damage from Spinal Cord Injury. Disabled World (DW). Retrieved February 12, 2025 from www.disabled-world.com/disability/types/spinal/inflammation-sci.php

Permalink: <a href="https://www.disabled-world.com/disability/types/spinal/inflammation-sci.php">Shutting Down Inflammation Reverses Damage from Spinal Cord Injury</a>: Researchers have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.